Your browser doesn't support javascript.
loading
SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing.
Mezzadra, Riccardo; de Bruijn, Marjolein; Jae, Lucas T; Gomez-Eerland, Raquel; Duursma, Anja; Scheeren, Ferenc A; Brummelkamp, Thijn R; Schumacher, Ton N.
Affiliation
  • Mezzadra R; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Bruijn M; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jae LT; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Gomez-Eerland R; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Duursma A; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Scheeren FA; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Brummelkamp TR; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schumacher TN; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
PLoS One ; 14(2): e0212053, 2019.
Article in En | MEDLINE | ID: mdl-30753225

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / T-Lymphocytes, Cytotoxic / Interferon-gamma / Apoptosis Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / T-Lymphocytes, Cytotoxic / Interferon-gamma / Apoptosis Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Type: Article Affiliation country: Netherlands